Survanta 8ml Injection

About Survanta 8ml Injection

Survanta 8 ml (Beractant 200 mg Injection) is a pulmonary surfactant medicine used to prevent and treat Respiratory Distress Syndrome (RDS) in premature newborns with a birth weight of 700 g or more. Extracted from bovine lungs, Beractant helps newborns lungs function properly by reducing surface tension and improving breathing efficiency. Survanta Injection is vital for preterm infantsespecially those born before 32 weekswho are at high risk of RDS and require endotracheal intubation for stabilization. Manufactured under strict quality standards, this medication supports neonatal respiratory care in critical situations. Parents and healthcare professionals should use it only under medical supervision. Common side effects may include noisy breathing, feeding difficulties, or mild bleeding around the endotracheal tube. Always consult a qualified neonatologist before use and report any signs of allergy or adverse reactiontoBeractant.

Effective Anti-Bacterial Solution

Survanta 8ml Injection delivers targeted anti-bacterial action to help manage various bacterial infections. Featuring Sevoflurane, this medicine is suitable for adult patients under a doctors prescription. Its precise formulation aids in ensuring reliable efficacy while minimizing the risk of resistance, making it a trusted choice for healthcare providers.


Professional Usage and Storage

This injection is intended for use by doctors or under their guidance. To maintain its quality, it must be stored in a cool and dry place away from direct sunlight. Adhering to storage and handling instructions ensures the medicinal properties remain intact and effective throughout its shelf life.